0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Asthma and COPD Drug Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-24N6793
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Asthma and COPD Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Global Asthma and COPD Drug Market Research Report 2024

Code: QYRE-Auto-24N6793
Report
March 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Asthma and COPD Drug Market Size

The global Asthma and COPD Drug market was valued at US$ 12560 million in 2023 and is anticipated to reach US$ 15210 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.

Asthma and COPD Drug Market

Asthma and COPD Drug Market

Asthma and chronic obstructive pulmonary disease (COPD) drugs are medications used to manage and treat respiratory conditions.
The market for asthma and COPD drugs is driven by the high prevalence of respiratory diseases and the increasing demand for effective and personalized treatments. The growing awareness of respiratory health and the development of novel therapeutics further boost the market growth.
This report aims to provide a comprehensive presentation of the global market for Asthma and COPD Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma and COPD Drug.

Report Scope

The Asthma and COPD Drug market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma and COPD Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma and COPD Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Asthma and COPD Drug Market Report

Report Metric Details
Report Name Asthma and COPD Drug Market
Accounted market size in 2023 US$ 12560 million
Forecasted market size in 2030 US$ 15210 million
CAGR 2.3%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Bronchodilators
  • Anti-inflammatory Drugs
  • Monoclonal Antibodies
  • Combination Drugs
Segment by Application
  • Asthma
  • COPD
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, GlaxoSmithKline, Merck and Co, Novartis AG, AstraZeneca, F. Hoffmann-La Roche
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Asthma and COPD Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Asthma and COPD Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Asthma and COPD Drug Market growing?

Ans: The Asthma and COPD Drug Market witnessing a CAGR of 2.3% during the forecast period 2024-2030.

What is the Asthma and COPD Drug Market size in 2030?

Ans: The Asthma and COPD Drug Market size in 2030 will be US$ 15210 million.

Who are the main players in the Asthma and COPD Drug Market report?

Ans: The main players in the Asthma and COPD Drug Market are Boehringer Ingelheim, GlaxoSmithKline, Merck and Co, Novartis AG, AstraZeneca, F. Hoffmann-La Roche

What are the Application segmentation covered in the Asthma and COPD Drug Market report?

Ans: The Applications covered in the Asthma and COPD Drug Market report are Asthma, COPD

What are the Type segmentation covered in the Asthma and COPD Drug Market report?

Ans: The Types covered in the Asthma and COPD Drug Market report are Bronchodilators, Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs

1 Asthma and COPD Drug Market Overview
1.1 Product Overview and Scope of Asthma and COPD Drug
1.2 Asthma and COPD Drug Segment by Type
1.2.1 Global Asthma and COPD Drug Market Value Comparison by Type (2024-2030)
1.2.2 Bronchodilators
1.2.3 Anti-inflammatory Drugs
1.2.4 Monoclonal Antibodies
1.2.5 Combination Drugs
1.3 Asthma and COPD Drug Segment by Application
1.3.1 Global Asthma and COPD Drug Market Value by Application: (2024-2030)
1.3.2 Asthma
1.3.3 COPD
1.4 Global Asthma and COPD Drug Market Size Estimates and Forecasts
1.4.1 Global Asthma and COPD Drug Revenue 2019-2030
1.4.2 Global Asthma and COPD Drug Sales 2019-2030
1.4.3 Global Asthma and COPD Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Asthma and COPD Drug Market Competition by Manufacturers
2.1 Global Asthma and COPD Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Asthma and COPD Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Asthma and COPD Drug Average Price by Manufacturers (2019-2024)
2.4 Global Asthma and COPD Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Asthma and COPD Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Asthma and COPD Drug, Product Type & Application
2.7 Asthma and COPD Drug Market Competitive Situation and Trends
2.7.1 Asthma and COPD Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Asthma and COPD Drug Players Market Share by Revenue
2.7.3 Global Asthma and COPD Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Asthma and COPD Drug Retrospective Market Scenario by Region
3.1 Global Asthma and COPD Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Asthma and COPD Drug Global Asthma and COPD Drug Sales by Region: 2019-2030
3.2.1 Global Asthma and COPD Drug Sales by Region: 2019-2024
3.2.2 Global Asthma and COPD Drug Sales by Region: 2025-2030
3.3 Global Asthma and COPD Drug Global Asthma and COPD Drug Revenue by Region: 2019-2030
3.3.1 Global Asthma and COPD Drug Revenue by Region: 2019-2024
3.3.2 Global Asthma and COPD Drug Revenue by Region: 2025-2030
3.4 North America Asthma and COPD Drug Market Facts & Figures by Country
3.4.1 North America Asthma and COPD Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Asthma and COPD Drug Sales by Country (2019-2030)
3.4.3 North America Asthma and COPD Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Asthma and COPD Drug Market Facts & Figures by Country
3.5.1 Europe Asthma and COPD Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Asthma and COPD Drug Sales by Country (2019-2030)
3.5.3 Europe Asthma and COPD Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Asthma and COPD Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Asthma and COPD Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Asthma and COPD Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Asthma and COPD Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Asthma and COPD Drug Market Facts & Figures by Country
3.7.1 Latin America Asthma and COPD Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Asthma and COPD Drug Sales by Country (2019-2030)
3.7.3 Latin America Asthma and COPD Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Asthma and COPD Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Asthma and COPD Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Asthma and COPD Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Asthma and COPD Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Asthma and COPD Drug Sales by Type (2019-2030)
4.1.1 Global Asthma and COPD Drug Sales by Type (2019-2024)
4.1.2 Global Asthma and COPD Drug Sales by Type (2025-2030)
4.1.3 Global Asthma and COPD Drug Sales Market Share by Type (2019-2030)
4.2 Global Asthma and COPD Drug Revenue by Type (2019-2030)
4.2.1 Global Asthma and COPD Drug Revenue by Type (2019-2024)
4.2.2 Global Asthma and COPD Drug Revenue by Type (2025-2030)
4.2.3 Global Asthma and COPD Drug Revenue Market Share by Type (2019-2030)
4.3 Global Asthma and COPD Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Asthma and COPD Drug Sales by Application (2019-2030)
5.1.1 Global Asthma and COPD Drug Sales by Application (2019-2024)
5.1.2 Global Asthma and COPD Drug Sales by Application (2025-2030)
5.1.3 Global Asthma and COPD Drug Sales Market Share by Application (2019-2030)
5.2 Global Asthma and COPD Drug Revenue by Application (2019-2030)
5.2.1 Global Asthma and COPD Drug Revenue by Application (2019-2024)
5.2.2 Global Asthma and COPD Drug Revenue by Application (2025-2030)
5.2.3 Global Asthma and COPD Drug Revenue Market Share by Application (2019-2030)
5.3 Global Asthma and COPD Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Asthma and COPD Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Asthma and COPD Drug Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Asthma and COPD Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GlaxoSmithKline Asthma and COPD Drug Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Merck and Co
6.3.1 Merck and Co Corporation Information
6.3.2 Merck and Co Description and Business Overview
6.3.3 Merck and Co Asthma and COPD Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck and Co Asthma and COPD Drug Product Portfolio
6.3.5 Merck and Co Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Asthma and COPD Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis AG Asthma and COPD Drug Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Asthma and COPD Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Asthma and COPD Drug Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 F. Hoffmann-La Roche
6.6.1 F. Hoffmann-La Roche Corporation Information
6.6.2 F. Hoffmann-La Roche Description and Business Overview
6.6.3 F. Hoffmann-La Roche Asthma and COPD Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 F. Hoffmann-La Roche Asthma and COPD Drug Product Portfolio
6.6.5 F. Hoffmann-La Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Asthma and COPD Drug Industry Chain Analysis
7.2 Asthma and COPD Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Asthma and COPD Drug Production Mode & Process
7.4 Asthma and COPD Drug Sales and Marketing
7.4.1 Asthma and COPD Drug Sales Channels
7.4.2 Asthma and COPD Drug Distributors
7.5 Asthma and COPD Drug Customers
8 Asthma and COPD Drug Market Dynamics
8.1 Asthma and COPD Drug Industry Trends
8.2 Asthma and COPD Drug Market Drivers
8.3 Asthma and COPD Drug Market Challenges
8.4 Asthma and COPD Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Asthma and COPD Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Asthma and COPD Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Asthma and COPD Drug Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Asthma and COPD Drug Sales (MT) of Key Manufacturers (2019-2024)
    Table 5. Global Asthma and COPD Drug Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Asthma and COPD Drug Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Asthma and COPD Drug Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Asthma and COPD Drug Average Price (USD/Kg) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Asthma and COPD Drug, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Asthma and COPD Drug, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Asthma and COPD Drug, Product Type & Application
    Table 12. Global Key Manufacturers of Asthma and COPD Drug, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Asthma and COPD Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma and COPD Drug as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Asthma and COPD Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Asthma and COPD Drug Sales by Region (2019-2024) & (MT)
    Table 18. Global Asthma and COPD Drug Sales Market Share by Region (2019-2024)
    Table 19. Global Asthma and COPD Drug Sales by Region (2025-2030) & (MT)
    Table 20. Global Asthma and COPD Drug Sales Market Share by Region (2025-2030)
    Table 21. Global Asthma and COPD Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Asthma and COPD Drug Revenue Market Share by Region (2019-2024)
    Table 23. Global Asthma and COPD Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Asthma and COPD Drug Revenue Market Share by Region (2025-2030)
    Table 25. North America Asthma and COPD Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Asthma and COPD Drug Sales by Country (2019-2024) & (MT)
    Table 27. North America Asthma and COPD Drug Sales by Country (2025-2030) & (MT)
    Table 28. North America Asthma and COPD Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Asthma and COPD Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Asthma and COPD Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Asthma and COPD Drug Sales by Country (2019-2024) & (MT)
    Table 32. Europe Asthma and COPD Drug Sales by Country (2025-2030) & (MT)
    Table 33. Europe Asthma and COPD Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Asthma and COPD Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Asthma and COPD Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Asthma and COPD Drug Sales by Region (2019-2024) & (MT)
    Table 37. Asia Pacific Asthma and COPD Drug Sales by Region (2025-2030) & (MT)
    Table 38. Asia Pacific Asthma and COPD Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Asthma and COPD Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Asthma and COPD Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Asthma and COPD Drug Sales by Country (2019-2024) & (MT)
    Table 42. Latin America Asthma and COPD Drug Sales by Country (2025-2030) & (MT)
    Table 43. Latin America Asthma and COPD Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Asthma and COPD Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Asthma and COPD Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Asthma and COPD Drug Sales by Country (2019-2024) & (MT)
    Table 47. Middle East & Africa Asthma and COPD Drug Sales by Country (2025-2030) & (MT)
    Table 48. Middle East & Africa Asthma and COPD Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Asthma and COPD Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Asthma and COPD Drug Sales (MT) by Type (2019-2024)
    Table 51. Global Asthma and COPD Drug Sales (MT) by Type (2025-2030)
    Table 52. Global Asthma and COPD Drug Sales Market Share by Type (2019-2024)
    Table 53. Global Asthma and COPD Drug Sales Market Share by Type (2025-2030)
    Table 54. Global Asthma and COPD Drug Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Asthma and COPD Drug Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Asthma and COPD Drug Revenue Market Share by Type (2019-2024)
    Table 57. Global Asthma and COPD Drug Revenue Market Share by Type (2025-2030)
    Table 58. Global Asthma and COPD Drug Price (USD/Kg) by Type (2019-2024)
    Table 59. Global Asthma and COPD Drug Price (USD/Kg) by Type (2025-2030)
    Table 60. Global Asthma and COPD Drug Sales (MT) by Application (2019-2024)
    Table 61. Global Asthma and COPD Drug Sales (MT) by Application (2025-2030)
    Table 62. Global Asthma and COPD Drug Sales Market Share by Application (2019-2024)
    Table 63. Global Asthma and COPD Drug Sales Market Share by Application (2025-2030)
    Table 64. Global Asthma and COPD Drug Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Asthma and COPD Drug Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Asthma and COPD Drug Revenue Market Share by Application (2019-2024)
    Table 67. Global Asthma and COPD Drug Revenue Market Share by Application (2025-2030)
    Table 68. Global Asthma and COPD Drug Price (USD/Kg) by Application (2019-2024)
    Table 69. Global Asthma and COPD Drug Price (USD/Kg) by Application (2025-2030)
    Table 70. Boehringer Ingelheim Corporation Information
    Table 71. Boehringer Ingelheim Description and Business Overview
    Table 72. Boehringer Ingelheim Asthma and COPD Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 73. Boehringer Ingelheim Asthma and COPD Drug Product
    Table 74. Boehringer Ingelheim Recent Developments/Updates
    Table 75. GlaxoSmithKline Corporation Information
    Table 76. GlaxoSmithKline Description and Business Overview
    Table 77. GlaxoSmithKline Asthma and COPD Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 78. GlaxoSmithKline Asthma and COPD Drug Product
    Table 79. GlaxoSmithKline Recent Developments/Updates
    Table 80. Merck and Co Corporation Information
    Table 81. Merck and Co Description and Business Overview
    Table 82. Merck and Co Asthma and COPD Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 83. Merck and Co Asthma and COPD Drug Product
    Table 84. Merck and Co Recent Developments/Updates
    Table 85. Novartis AG Corporation Information
    Table 86. Novartis AG Description and Business Overview
    Table 87. Novartis AG Asthma and COPD Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 88. Novartis AG Asthma and COPD Drug Product
    Table 89. Novartis AG Recent Developments/Updates
    Table 90. AstraZeneca Corporation Information
    Table 91. AstraZeneca Description and Business Overview
    Table 92. AstraZeneca Asthma and COPD Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 93. AstraZeneca Asthma and COPD Drug Product
    Table 94. AstraZeneca Recent Developments/Updates
    Table 95. F. Hoffmann-La Roche Corporation Information
    Table 96. F. Hoffmann-La Roche Description and Business Overview
    Table 97. F. Hoffmann-La Roche Asthma and COPD Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 98. F. Hoffmann-La Roche Asthma and COPD Drug Product
    Table 99. F. Hoffmann-La Roche Recent Developments/Updates
    Table 100. Key Raw Materials Lists
    Table 101. Raw Materials Key Suppliers Lists
    Table 102. Asthma and COPD Drug Distributors List
    Table 103. Asthma and COPD Drug Customers List
    Table 104. Asthma and COPD Drug Market Trends
    Table 105. Asthma and COPD Drug Market Drivers
    Table 106. Asthma and COPD Drug Market Challenges
    Table 107. Asthma and COPD Drug Market Restraints
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Asthma and COPD Drug
    Figure 2. Global Asthma and COPD Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Asthma and COPD Drug Market Share by Type in 2023 & 2030
    Figure 4. Bronchodilators Product Picture
    Figure 5. Anti-inflammatory Drugs Product Picture
    Figure 6. Monoclonal Antibodies Product Picture
    Figure 7. Combination Drugs Product Picture
    Figure 8. Global Asthma and COPD Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Asthma and COPD Drug Market Share by Application in 2023 & 2030
    Figure 10. Asthma
    Figure 11. COPD
    Figure 12. Global Asthma and COPD Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Asthma and COPD Drug Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Asthma and COPD Drug Sales (2019-2030) & (MT)
    Figure 15. Global Asthma and COPD Drug Average Price (USD/Kg) & (2019-2030)
    Figure 16. Asthma and COPD Drug Report Years Considered
    Figure 17. Asthma and COPD Drug Sales Share by Manufacturers in 2023
    Figure 18. Global Asthma and COPD Drug Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Asthma and COPD Drug Players: Market Share by Revenue in 2023
    Figure 20. Asthma and COPD Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Asthma and COPD Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Asthma and COPD Drug Sales Market Share by Country (2019-2030)
    Figure 23. North America Asthma and COPD Drug Revenue Market Share by Country (2019-2030)
    Figure 24. U.S. Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Asthma and COPD Drug Sales Market Share by Country (2019-2030)
    Figure 27. Europe Asthma and COPD Drug Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Asthma and COPD Drug Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Asthma and COPD Drug Revenue Market Share by Region (2019-2030)
    Figure 35. China Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Taiwan Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Philippines Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Asthma and COPD Drug Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Asthma and COPD Drug Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Asthma and COPD Drug Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Asthma and COPD Drug Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. U.A.E Asthma and COPD Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Asthma and COPD Drug by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Asthma and COPD Drug by Type (2019-2030)
    Figure 57. Global Asthma and COPD Drug Price (USD/Kg) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Asthma and COPD Drug by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Asthma and COPD Drug by Application (2019-2030)
    Figure 60. Global Asthma and COPD Drug Price (USD/Kg) by Application (2019-2030)
    Figure 61. Asthma and COPD Drug Value Chain
    Figure 62. Asthma and COPD Drug Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Family Asthma Management Product Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33S10320
Sun Apr 07 00:00:00 UTC 2024

Add to Cart

Global Disposable Oropharyngeal Airway Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25D8684
Wed Mar 20 00:00:00 UTC 2024

Add to Cart

Global PC-Based Spirometer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37U6932
Wed Mar 20 00:00:00 UTC 2024

Add to Cart

Global Respiratory Assistance Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-24S8616
Wed Mar 20 00:00:00 UTC 2024

Add to Cart